NMPA Approval

Levetiracetam Concentrated Solution for Injection

Approval Number

国药准字H20243584

Company黑龙江珍宝岛药业股份有限公司

Registration Date

April 24, 2024

Drug Information

Generic Name

左乙拉西坦注射用浓溶液

Dosage Form

注射剂

Strength

5ml:500mg

Drug Type

化学药品

Registration Date

April 24, 2024

Company Information

Applicant Company

Company Name黑龙江珍宝岛药业股份有限公司

Company Address

黑龙江省鸡西市虎林市虎林镇红星街72号

Manufacturing Company

Company Name黑龙江珍宝岛药业股份有限公司

Company Address

黑龙江省虎林市红星街72号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

左乙拉西坦注射用浓溶液 - NMPA 批准文号 | MedPath